Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the company will present updated safety and efficacy ...

Two oral and seven poster presentations further support the CARVYKTI® research in multiple myeloma First-in-Human Phase 1 data for allogeneic CAR-T cell therapy for NHL to be featured in oral session ...

Anthropologist Christopher Bae has recently suggested we add two new species of ancient human to our family tree. The plans break the conventions for how species should be named – but Bae argues the r ...

Genetic testing is transforming healthcare through personalized medicine, enabling early diagnosis, targeted treatments, and a future of more precise, patient-centered care.

A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.

David Fououhi has been installed as EPA deputy administrator under Administrator Lee Zeldin, himself a former Army intelligence officer and Republican congressman. Fououhi is a lawyer who has fought ...